DOCSLIB.ORG

The Fip Centennial Congress in Amsterdam!

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Fip Centennial Congress in Amsterdam! The FIP Centennial Improving health through responsible medicines use The future of pharmacy, be part of the creation! OCTOBER AMSTERDAM, THE NETHERLANDS www.fip.org/amsterdam2012 program_coverA4_def.indd 3 30-01-12 17:43 TIMELINE FIRST REGISTRATION DEADLINE JUNE SECOND REGISTRATION DEADLINE SEPTEMBER STAKEHOLDER ROUNDTABLES OCTOBER (BY INVITATION ONLY) MINISTERS SUMMIT OCTOBER (BY INVITATION ONLY) CONGRESS OPENS OCTOBER OPENING CEREMONY FOLLOWED BY OPENING EXHIBITION AND SHOWCASE OCTOBER WELCOME RECEPTION OCTOBER AMSTERDAM MUSEUM EVENING OCTOBER SECTION DINNERS OCTOBER CLOSING DINNER EVENT OCTOBER world congress of pharmacy and pharmaceutical sciences 2012 program_imagesA4_def.indd 4 30-01-12 12:37 TIMELINE Welcome to the FIP Centennial Congress in Amsterdam! FIRST REGISTRATION DEADLINE Network and connect with pharmacists and pharmaceutical The main theme of the Centennial is Improving Health Through JUNE scientists from all over the world under the theme of Responsible Medicines Use, a theme that calls on pharmacists ‘Improving Health Through Responsible Medicines Use’. and pharmaceutical scientists to take their place as leaders in SECOND REGISTRATION DEADLINE the healthcare team and do their part to usher in a new era of SEPTEMBER The chance to meet colleagues from every corner of the globe healthcare on a global scale. The theme will be supported by a is yours at the FIP World Congress of Pharmacy and world-class programme of expert speakers, symposia, Pharmaceutical Sciences. The FIP Congress is the leading workshops and posters that will bring together participants STAKEHOLDER ROUNDTABLES international event offering diverse learning opportunities for from diverse areas of pharmacy practice and pharmaceutical OCTOBER (BY INVITATION ONLY) those active within all areas of pharmacy. science. MINISTERS SUMMIT In 2012, FIP will celebrate its 100 year anniversary and as such In addition to the stellar congress programme, the Dutch OCTOBER (BY INVITATION ONLY) will host the FIP Centennial Congress, taking place 3-8 October Ministry of Health is organising a coinciding Ministers Summit in Amsterdam, The Netherlands – the home country of FIP on The benefits of responsible use of medicines - Setting poli- since its beginning. This Congress will not only be a unique cies for better and cost effective healthcare. Supportive CONGRESS OPENS opportunity for FIP to make a significant step in the fulfilment Stakeholder Roundtable sessions will elevate the FIP OCTOBER of our Vision and Mission, as adopted by the FIP Council in Centennial to a world-class, globally influential event. 2008, but will be a turning point for the profession on a global OPENING CEREMONY level. All present will set the stage for the future on a founda- Join your peers and colleagues at the FIP Centennial Congress – FOLLOWED BY OPENING EXHIBITION AND tion of 100 years of progress. steer your future and the future of pharmacy! SHOWCASE The Centennial will offer all participants an invaluable venue OCTOBER for enriching their career while at the same time participating in events and decisions that will steer the future of pharmacy WELCOME RECEPTION and healthcare around the world. OCTOBER AMSTERDAM MUSEUM EVENING Michel Buchmann Jan Smits President President OCTOBER International Royal Dutch Pharmacists’ Association (KNMP) Pharmaceutical Federation (FIP) SECTION DINNERS OCTOBER CLOSING DINNER EVENT OCTOBER 72nd International FIP Centennial Congress of Pharmacy and Pharmaceutical Sciences Your Hosts: CONGRESS INFORMATION The International Pharmaceutical Federation (FIP) FIP Congresses & Conferences together with the P.O. Box 84200 Royal Dutch Pharmacists’ Association (KNMP) 2508 AE The Hague The Netherlands RAI VISITING ADDRESS Tel.: (+31) (0)70 302 1982 Fax: (+31) (0)70 302 1998 E-mail: [email protected] Europaplein 22 Website: www.fip.org/amsterdam2012 1078 GZ Amsterdam The Netherlands 72nd internaTIONAL CONGRESS OF FIP 3 program_imagesA4_def.indd 4 30-01-12 12:37 Your Hosts FIP and KNMP THE INTERNATIONAL PHARMACEUTICAL FEDERATIon (FIP) ROyaL DUTCH PHARMACIsts’ AssoCIATIon (KNMP) Founded in 1912, the International Pharmaceutical Federation As a founding Member Organisation of FIP, KNMP is focused on (FIP) is the global federation of national associations of assisting pharmacists in the daily practice, management and pharmacists and pharmaceutical scientists and is in official quality of their profession. The KNMP formulates a perception relations with the World Health Organization (WHO). of the profession, strives for excellent pharmaceutical care for Through its 126 Member Organisations FIP represents and patients and the provision of drugs and stimulates the scientific serves more than two million practitioners and scientists practice of the pharmaceutical sector in The Netherlands. around the world. KNMP is thrilled to co-host this unique event. FIP LEADERSHIP KNMP LEADERSHIP Michel Buchmann President Jan Smits Chair Kamal Midha Immediate Past President Léon Tinke Co-Chair Ton Hoek General Secretary Ruud Dessing Member Henri Manasse Professional Secretary Fons Duchateau Member Henk de Jong Scientific Secretary Maayke Fluitman Member Andy Gray Chairman, Board of Pharmaceutical Practice Paul Haarbosch Member Mitsuru Hashida Chairman, Board of Pharmaceutical Sciences Mieke van Hattum Member John Bell Vice President Jean Hermans Member Thony Björk Vice President Bart Smals Member Niels Kristensen Vice President Frans van der Vaart Member Carmen Peña Vice President Remco Velasquez Member Mario Rocci Vice President Marianne Verhoeven Member Prafull Sheth Vice President Philip Schneider Vice President FIP CENTENNIAL PROGRAMME COMMIttee (CPC) Geoffrey Tucker Vice President Philip Schneider Co-Chair Régis Vaillancourt Vice President Martin Schulz Co-Chair Dieter Steinbach Honorary President Luc Besançon Member Joseph Oddis Honorary President Douwe Breimer Member Robert DeChristoforo Member FIP STAFF Han de Gier Member Luc Besançon Manager Scientific & Professional Affairs Linda Hakes Member Mireille van Boldrik Event Manager Lindsay McClure Member Andreia Bruno FIPEd Project Coordinator Ross McKinnon Member Paula Cohen Secretary Ema Paulino Member Diane Gal Project Manager Geoffrey Tucker Member Carola van der Hoeff Congress Director Frans van de Vaart Member Rachel van Kesteren Executive Secretary Myriah Lesko Manager Media and Publications ORGANISING COMMITTEE Gonçalo Sousa Pinto Liaison Officer for Latin America Ton Hoek Chair Oliver van der Spek Manager Marketing & Public Relations Philip Schneider Chair of the Programme Committee Sarah Whitmarsh FIPEd Communications Liaison Michel Buchmann Chair of the Centennial Declaration Committee CENTENNIAL STEERING COMMITTEE Jan Smits Chair of the Ministers Summit Committee Michel Buchmann President FIP, Chair Léon Tinke Chair of the Fundraising and Kamal Midha Immdeiate past President FIP, Link to Exhibition Committee Stakeholders Round Tables Committee Remco Velazques Chair of the Finance Committee Jan Smits Link to KNMP Marianne Verhoeven Chair of the Social Events Committee Douwe Breimer Link to Programme Committee Oliver van der Spek Chair Marketing and Communications Ton Hoek Link to the Organizing Committee Committee Carola van der Hoeff Congress Director Mireille van Boldrik Event Manager Luc Besançon Scientific and Professional Affairs Myriah Lesko Media, Communications and Publications 4 world congress of pharmacy and pharmaceutical sciences 2012 Table of Contents for Preliminary Programme Sponsors 6 How to Register 7 General Events 9 Social Events and Exhibition 10 Accreditation and Continuing Education 11 Sessions Overview 12 Congress Sessions Topic 1: The Healthcare Team of the Future 15 Topic 2: The Medicines of the Future 18 Topic 3: Safe Medicines, Safe Patients – How safe is safe? 21 Topic 4: The Core of Pharmacy Now and in the Future – Ensuring responsible medicines use 23 Topic 5: The Future Medicines Supply Chain 29 Topic 6: The Future Healthcare Economy – Will we shape it or will it shape us? 32 Topic 7: Adherence – Helping patients take their medicines 35 Topic 8: Back to the Future! Miscellaneous Sessions 8A: Going Dutch – Pharmacy Practice in The Netherlands 37 8B: Pharmacy Education 37 8C: Policy and Regulation 39 8D: Science Meets Practice 40 8E: Pharmacists in Humanitarian Work 41 8F: Short Oral Communications (SOC), various topics 41 8G: History of Pharmacy 42 Additional Programme Items 44 General Information 46 Abstract Information 47 72nd internaTIONAL CONGRESS OF FIP 5 Sponsors Congratulations FIP on your 100 years! Supporting the FIP Centennial Since its inception in 1912, FIP has endeavoured – and, more importantly, succeeded - to advance pharmaceutical sciences and pharmacy practice on a global level, in turn positively influencing the health of communities the world over. As such, it is our pleasure to congratulate and support FIP on this remarkable achievement of their Centennial. The Federation has shown us, its partners and fellow stakeholders, the progress that can be made in fulfilling our mutual goal by working together and contributing the best each has to offer. CONGRATULATIons FIP – we lOOK FORWArd to 100 YEARS More! 6 world congress of pharmacy and pharmaceutical sciences 2012 program_imagesA4_def.indd 1 18-01-12 13:18 How to Register REGISTRATION PROCESS Payment of registration fee * By credit card through a secured site, ONLY during the online registration process. * By bank transfer after receipt of an invoice.
Load more

Recommended publications
  • Research Review
    Research Review Faculty of Science and Engineering University of Groningen 2017 Quality Assurance Netherlands Universities (QANU) Catharijnesingel 56 PO Box 8035 3503 RA Utrecht The Netherlands Phone: +31 (0) 30 230 3100 E-mail: [email protected] Internet: www.qanu.nl Project number: 0651 © 2017 QANU Text and numerical material from this publication may be reproduced in print, by photocopying or by any other means with the permission of QANU if the source is mentioned. 2 Research review Faculty of Science and Engineering, University of Groningen CONTENTS 1. INTRODUCTION COMMITTEE CHAIR ............................................................................. 5 2. THE REVIEW COMMITTEE AND THE PROCEDURES ........................................................ 7 3. GENERAL REMARKS AT FACULTY LEVEL ...................................................................... 11 4. GRADUATE SCHOOL OF SCIENCE AND ENGINEERING ................................................. 19 5. REVIEW OF THE VAN SWINDEREN INSTITUTE FOR PARTICLE PHYSICS AND GRAVITY (VSI) .............................................................................................................................. 23 6. REVIEW OF THE ENGINEERING AND TECHNOLOGY INSTITUTE GRONINGEN (ENTEG) 27 7. REVIEW OF THE ZERNIKE INSTITUTE FOR ADVANCED MATERIALS (ZIAM) ................ 31 8. REVIEW OF THE STRATINGH INSTITUTE FOR CHEMISTRY ......................................... 35 9. REVIEW OF THE GRONINGEN BIOMOLECULAR SCIENCES AND BIOTECHNOLOGY INSTITUTE (GBB) ..........................................................................................................
    [Show full text]
  • Research Review
    Research Review Faculty of Science and Engineering University of Groningen 2017 Quality Assurance Netherlands Universities (QANU) Catharijnesingel 56 PO Box 8035 3503 RA Utrecht The Netherlands Phone: +31 (0) 30 230 3100 E-mail: [email protected] Internet: www.qanu.nl Project number: 0651 © 2017 QANU Text and numerical material from this publication may be reproduced in print, by photocopying or by any other means with the permission of QANU if the source is mentioned. 2 Research review Faculty of Science and Engineering, University of Groningen CONTENTS 1. INTRODUCTION COMMITTEE CHAIR ............................................................................. 5 2. THE REVIEW COMMITTEE AND THE PROCEDURES ........................................................ 7 3. GENERAL REMARKS AT FACULTY LEVEL ...................................................................... 11 4. GRADUATE SCHOOL OF SCIENCE AND ENGINEERING ................................................. 19 5. REVIEW OF THE VAN SWINDEREN INSTITUTE FOR PARTICLE PHYSICS AND GRAVITY (VSI) .............................................................................................................................. 23 6. REVIEW OF THE ENGINEERING AND TECHNOLOGY INSTITUTE GRONINGEN (ENTEG) 27 7. REVIEW OF THE ZERNIKE INSTITUTE FOR ADVANCED MATERIALS (ZIAM) ................ 31 8. REVIEW OF THE STRATINGH INSTITUTE FOR CHEMISTRY ......................................... 35 9. REVIEW OF THE GRONINGEN BIOMOLECULAR SCIENCES AND BIOTECHNOLOGY INSTITUTE (GBB) ..........................................................................................................
    [Show full text]
  • 33V449 Afscheidscollege Danhof-Special.Indd
    Prof.dr. Meindert Danhof Bespiegelingen over Farmacologie Reflections on Pharmacology Bij ons leer je de wereld kennen Bespiegelingen over Farmacologie Reflections on Pharmacology Meindert Danhof Leiden Academic Centre for Drugs Research Leiden University P.O. Box 9502 2300 RA Leiden The Netherlands Translation and editorial support: Corine Visser ISBN: 978-90-9030260-7 Copyright © Meindert Danhof, 2017 No part of this publication may be reproduced or transmitted in any form or by any means without written permission of the author. Content Bespiegelingen over Farmacologie 5 Reflections on Pharmacology 31 Appendices 53 Appendix A: Reflections on Pharmacology 55 “Four Decades of Research on Pharmacokinetics & Pharmacodynamics” Leiden, 31 March 2017 Appendix B: Overview of PhD theses of the division of Pharmacology 59 Bespiegelingen over Farmacologie Rede uitgesproken door prof.dr. Meindert Danhof ter gelegenheid van zijn afscheid als hoogleraar in de Farmacologie aan de Universiteit Leiden op vrijdag 31 maart 2017 Prof. dr. Meindert Danhof Proloog In mijn afscheidsrede beschrijf ik de ontwikkelingen in het siologie waar, in experimenten in levende proefdieren, de be- geneesmiddelonderzoek in de bijna 41 jaar dat ik bij de vak- ginselen van de fysiologie werden uitgelegd. Het was een eerste groep Farmacologie en het LACDR werkzaam was. Deze pro- kennismaking met farmacologie. Daarbij dienen we ons te loog heeft betrekking op de periode die daaraan voorafging, en realiseren dat kennis van de fysiologie voor een belangrijk deel waarin mijn belangstelling werd gewekt voor de farmacologie. is verkregen door de bestudering van de effecten van farmaca. Terugkijkend moet ik bekennen dat ik niet heb durven dromen Mijn studentassistentschap bracht mij in contact met Anton dat een loopbaan in het wetenschappelijk onderzoek mij ten Steffens, van oorsprong apotheker, werkzaam als onderzoeker deel zou vallen.
    [Show full text]
  • 3-8 October 2012 Amsterdam, the Netherlands WELCOME to the FIP
    Congress Programme The FIP Centennial The future of pharmacy, Improving health be part of the creation! through responsible medicines use 3-8 october 2012 AMSTERDAM, THE NETHERLANDS WELCOME TO THE FIP. CENTENNIAL CONGRESS. IN AMSTERDAM!. Network and connect with pharmacists and pharmaceutical scientists from all over the world under the theme of ‘Improving health through responsible medicines use’. The chance to meet colleagues from every corner of the globe is here and yours, at the FIP World Congress of Pharmacy and Pharmaceutical Sciences, the leading interna tional event offering diverse learning opportunities for those active within all areas of pharmacy. In 2012, FIP is celebrating its 100 year anniversary and as such The main theme of the Centennial is Improving Health through hosting this FIP Centennial Congress, taking place from 3-8 October Responsible Medicines Use, a theme that calls on pharmacists in ­Amsterdam, The Netherlands – the home country of FIP since and pharmaceutical scientists to take their place as leaders in the its beginning. This Congress is not only a unique opportunity for healthcare team and do their part to usher in a new era of health- FIP to make a significant step in the fulfilment of our Vision and care on a global scale. The theme is supported by a world-class Mission, as adopted by FIP Council in 2008, but will be a turning programme of expert speakers, symposia, workshops and posters point for the profession on a global level – all present will set the that bring together participants from diverse areas of pharmacy stage for the future on a foundation of 100 years of progress.
    [Show full text]
  • TI Pharma Report
    TI PHARMA NEW TRACKS TO MEDICINES KNOW-HOW PRIORITY MEDICINES HUMAN CAPITAL NETWORKS LEGACY FOR THE FUTURE TI Pharma New tracks to medicines 1. Executive summary 3 2. Background 6 3. Know-how 14 4. Priority medicines 28 5. Human capital 40 6. Networks 48 7. Finance & operations 58 8. Legacy for the future 64 9. Appendix A: FES Review Committee report 76 10. Appendix B: FES portfolio projects and partners 94 CHAPTER 1. EXECUTIVE SUMMARY Building health and wealth based on scientific excellence New tracks to medicines Public-private partnerships within pharmaceutical Know-how research are now so successful that it is easy to Improved health and wealth, rooted in scientific forget how unlikely they once seemed. Less than excellence, were central FES portfolio objectives. a decade ago, partnership between academic organisations, major industry players and SMEs was Direct patient benefits have already resulted, rare, and when they did occur, they were usually including a safe morphine regimen for newborns; within isolated silos of activity. new clinical protocols for COPD; a vaccine candidate against acute myeloid leukaemia; a disease registry The FES-funded (Dutch natural gas reserve fund) for rare metabolic diseases (which will facilitate research portfolio triggered the creation of the Top development for these so-called orphan diseases); Institute Pharma (TI Pharma). Following an invitation and numerous other examples. from large and small industry players and leading academic organisations, the Dutch government New test methods have been developed, and highly stepped in to encourage partnerships that could promising molecules and compound libraries have improve pharmaceutical research. This followed up been identified.
    [Show full text]